Categories: Technology

PROACTIS SA – Press Release (nomination C. Carter and P. Shepherd) 19.12.2025

Press Release

Evolution of PROACTIS SA Governance

PARIS, France – (19 December 2025) — Under the terms of the Board of Directors of the company PROACTIS SA (ISIN code: FR0004052561) held on the 18th of December 2025, Mrs. Charlotte CARTER has been appointed as Director in replacement of Mrs. Bonnie MITCHELL, resigning.

Charlotte Carter joined Proactis in 2013. She is Vice President for Product at Proactis, where she leads a high-performing team dedicated to investing in our next generation of software products. She brings over 12 years of experience in the Source-to-Pay software domain, with expertise in procurement, spend control and SaaS and is supported by CIPS certification and executive education from MIT Sloan.

During this same meeting, Mr. Peter SHEPHERD has been appointed as Director in replacement of Mr. Graham DAVIS, resigning.

Peter Shepherd joined Proactis in November 2025 after being CFO at Medical Management Systems LTD. He brings over 20 years of experience in senior financial roles, with strong expertise in strategy, growth management, and financial excellence within international organizations. His experience and leadership will be instrumental in helping Proactis Group continue its evolution.

Shareholders will be asked to approve these appointments at the next Annual General Meeting called to approve the financial statements for the year ended January 31st, 2026.

As a result of these changes, the Board of Directors of PROACTIS SA is now composed as follows:

Member Functions Mandate expiry date
Andrew REARDON Chairman of the Board of Directors
Chief Executive Officer
Annual General Meeting to approve the financial statements for the year ending January 31, 2028
Charlotte CARTER Director Annual General Meeting to approve the financial statements for the year ending January 31, 2030
Peter SHEPHERD Director Annual General Meeting to approve the financial statements for the year ending January 31, 2028
Maria LARSEN Director Annual General Meeting to approve the financial statements for the year ending January 31, 2028

* * * *

Contacts
Tel: +33 (0)1 53 25 55 00
E-mail: investorContact@proactis.com

* * * *

GlobeNews Wire

Recent Posts

Appili Therapeutics Reports Fiscal Year 2026 Financial and Operational Results

LIKMEZ® (ATI-1501) commercial momentum building in U.S. marketUS$40 million NIAID award supporting VXV-01 advancement through…

47 minutes ago

Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards and Acceptance of Plan to Regain Compliance

BEDMINSTER, N.J., June 26, 2026 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (the “Company”) (NYSE…

47 minutes ago

Neuphoria Responds to the announcement made by London-listed Scancell Holdings plc

June 26, 2026 16:15 ET  | Source: Neuphoria Therapeutics, Inc. Neuphoria Therapeutics confirms it is…

47 minutes ago

Global Tech Shift: Tune Talk Launches World’s First Network-Enforced Child Safety Mobile Plan, Bypassing App-Level Limitations

PETALING JAYA, Malaysia, June 26, 2026 /PRNewswire/ -- Malaysian mobile operator Tune Talk redefined the standard…

3 hours ago

MBA Students of Chandigarh University secure prestigious MNC internships; MNCs including Nestl, Lenovo & Berger offers internships

"Early Internship offers early corporate exposure to Chandigarh University students," says Jai Inder Sandhu LUCKNOW, India,…

3 hours ago

Yealink Upgrades Singapore Global Operational HQ and Opens New Customer Experience Center

SINGAPORE, June 26, 2026 /PRNewswire/ -- Yealink (300628.SZ), a global leader in Unified Communications and…

3 hours ago